Clinical Phenotypes of Patients with Anti-DFS70/LEDGF Antibodies in a Routine ANA Referral Cohort

Simple item page
dc.contributor.authorMiyara, Makoto
dc.contributor.authorAlbesa, Roger
dc.contributor.authorCharuel, Jean-Luc
dc.contributor.authorEl Amri, Mohamed
dc.contributor.authorFritzler, Marvin J.
dc.contributor.authorGhillani-Dalbin, Pascale
dc.contributor.authorAmoura, Zahir
dc.contributor.authorMusset, Lucile
dc.contributor.authorMahler, Michael
dc.date.accessioned2018-09-27T11:45:12Z
dc.date.available2018-09-27T11:45:12Z
dc.date.issued2013-02-07
dc.date.updated2018-09-27T11:45:12Z
dc.description.abstractObjective. To analyze the clinical value of anti-DFS70 antibodies in a cohort of patients undergoing routine antinuclear antibodies (ANAs) testing. Methods. Sera with a dense fine speckled (DFS) indirect immunofluorescence (IIF) pattern from 100 consecutive patients and 100 patients with other IIF patterns were tested for anti-DFS70 antibodies by a novel chemiluminescence immunoassay (CIA) and for ANA by ANA Screen ELISA (both INOVA). Results. Among the 100 patients with a DFS IIF pattern, 91% were anti-DFS70 positive by CIA compared to 3% in the comparator group . The CIA and IIF titers of anti-DFS antibodies were highly correlated (rho = 0.89). ANA by ELISA was positive in 35% of patients with the DFS IIF pattern as compared to 67% of patients with other patterns . Only 12.0% of patients with DFS pattern and 13.4% with DFS pattern and anti-DFS70 antibodies detected by CIA had systemic autoimmune rheumatic disease (SARD). Only 5/91 (5.5%) patients with anti-DFS70 antibodies had SARD and their sera were negative on the ANA Screen ELISA. Conclusion. Although anti-DFS70 antibodies cannot exclude the presence of SARD, the likelihood is significantly lower than in patients with other IIF patterns and should be included in test algorithms for ANA testing.
dc.description.versionPeer Reviewed
dc.identifier.citationMakoto Miyara, Roger Albesa, Jean-Luc Charuel, et al., “Clinical Phenotypes of Patients with Anti-DFS70/LEDGF Antibodies in a Routine ANA Referral Cohort,” Clinical and Developmental Immunology, vol. 2013, Article ID 703759, 8 pages, 2013. doi:10.1155/2013/703759
dc.identifier.doihttps://doi.org/10.1155/2013/703759
dc.identifier.urihttp://hdl.handle.net/1880/108300
dc.identifier.urihttps://doi.org/10.11575/PRISM/44029
dc.language.rfc3066en
dc.rights.holderCopyright © 2013 Makoto Miyara et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
dc.titleClinical Phenotypes of Patients with Anti-DFS70/LEDGF Antibodies in a Routine ANA Referral Cohort
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
JIR.2013.703759.pdf
Size:
685.35 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Publications